Metronome
A scheduled accumulation rule on a leveraged Nasdaq ETF.
A metronome keeps time and predicts nothing. Neither does this rule.
Measured on a single lump sum, so the return is a CAGR. The contribution strategy on this site reports an XIRR instead, and the two are not directly comparable.
Underlying at $81.28 on 2026-10-09. The size of the trade at each rebalance depends on where the ETF sits against the schedule.
The rule sets a higher target position value each quarter and trades whatever difference is needed to reach it, holding the remainder in cash. When the ETF runs ahead of schedule it sells into strength; when it falls behind, it buys. Nothing in it is a forecast. It is a schedule, which is why it keeps working through periods when a view would have been wrong.
This is one of three sleeves in the model portfolio, held at equal weight and rebalanced quarterly.
A 63% drawdown happened, and will happen again
The worst peak-to-trough fall in this backtest was 63.2%. That is the number that decides whether a strategy is holdable, and it matters more than the return, because a strategy abandoned at the bottom returns nothing at all. This curve is marked daily, so the drawdown below is the real peak-to-trough figure rather than a sampled one.
Backtested and hypothetical, over one historical window, with the benefit of hindsight. Costs, taxes and slippage are modelled only where the module notes say so. Nothing here is advice, and no result is a forecast.